Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Adverse effects | |||||
RCT |
7274 people with hypertension, suitable for treatment with nicardipine, age 18 years and older, mean age 50 years, 60% on current treatment. Other concomitant antihypertensive therapies allowed |
Pruritus
with nicardipine twice daily (slow release) with nicardipine 3 times daily Absolute results not reported |
P = 0.043 |
Effect size not calculated | simplified dosing |
RCT |
7274 people with hypertension, suitable for treatment with nicardipine, age 18 years and older, mean age 50 years, 60% on current treatment. Other concomitant antihypertensive therapies allowed |
Palpitations
with nicardipine twice daily (slow release) with nicardipine 3 times daily Absolute results not reported |
P = 0.033 |
Effect size not calculated | simplified dosing |
RCT |
7274 people with hypertension, suitable for treatment with nicardipine, age 18 years and older, mean age 50 years, 60% on current treatment. Other concomitant antihypertensive therapies allowed |
People with at least 1 adverse event
with nicardipine twice daily (slow release) with nicardipine 3 times daily Absolute results not reported |
P = 0.004 |
Effect size not calculated | simplified dosing |
RCT |
7274 people with hypertension, suitable for treatment with nicardipine, age 18 years and older, mean age 50 years, 60% on current treatment. Other concomitant antihypertensive therapies allowed |
Hot flushes
with nicardipine twice daily (slow release) with nicardipine 3 times daily Absolute results not reported |
P = 0.024 |
Effect size not calculated | simplified dosing |
RCT Crossover design |
29 men, participants in earlier study, mean age 49 years, on niacin 4 times daily plus lovastatin twice daily plus colestipol twice daily for 1 year, adjusted to maintain target cholesterol 150 mg/dL to 175 mg/dL, high risk of cardiac events (elevated apoprotein B or stenosis or strong family history). Other medication (lovastatin and colestipol) continued as before |
Flushing
14 people with niacin twice daily 6 people with niacin 4 times daily Absolute numbers not reported |
P <0.005 |
Effect size not calculated | complex dosing |